Following review, the MHRA has concluded that the available evidence no longer supports a positive benefit-risk balance for Avacopan Vifor (previously known as Tavneos), used in combination with rituximab or cyclophosphamide for adults with severe, active granulomatosis with polyangiitis (GPA) or...
Read more
Ginny Quan and Stephen John appointed Co-Chairs of Clinical Directors Group
The UK Kidney Association welcomes Ginny Quan and Stephen John as the new Co-Chairs of its Clinical Directors Group. The group brings together clinical directors from kidney services across the UK to share experience, discuss the major challenges and priorities affecting services and identify issues...
Read more
Transforming community voices into national action
Over the past 6 months, the kidney community has been campaigning to policymakers for a Kidney Disease Modern Service Framework. October 2025 - open letter calling for a national kidney disease strategy delivered to Prime Minister with over 13,000 signatures February – March 2026 – campaign action...
Read more
Loading content ...
Loading content ...